BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 23116200)

  • 1. New insight into the functions of the interleukin-17 receptor adaptor protein Act1 in psoriatic arthritis.
    Doyle MS; Collins ES; FitzGerald OM; Pennington SR
    Arthritis Res Ther; 2012 Oct; 14(5):226. PubMed ID: 23116200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Act1 modulates autoimmunity through its dual functions in CD40L/BAFF and IL-17 signaling.
    Li X
    Cytokine; 2008 Feb; 41(2):105-13. PubMed ID: 18061473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Act1, a U-box E3 ubiquitin ligase for IL-17 signaling.
    Liu C; Qian W; Qian Y; Giltiay NV; Lu Y; Swaidani S; Misra S; Deng L; Chen ZJ; Li X
    Sci Signal; 2009 Oct; 2(92):ra63. PubMed ID: 19825828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of low-frequency TRAF3IP2 coding variants in psoriatic arthritis patients and functional characterization.
    Böhm B; Burkhardt H; Uebe S; Apel M; Behrens F; Reis A; Hüffmeier U
    Arthritis Res Ther; 2012 Apr; 14(2):R84. PubMed ID: 22513239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NF-kappaB activator Act1 associates with IL-1/Toll pathway adaptor molecule TRAF6.
    Kanamori M; Kai C; Hayashizaki Y; Suzuki H
    FEBS Lett; 2002 Dec; 532(1-2):241-6. PubMed ID: 12459498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The differential regulation of human ACT1 isoforms by Hsp90 in IL-17 signaling.
    Wu L; Wang C; Boisson B; Misra S; Rayman P; Finke JH; Puel A; Casanova JL; Li X
    J Immunol; 2014 Aug; 193(4):1590-9. PubMed ID: 25024377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Nuclear Function for the Interleukin-17 Signaling Adaptor Protein Act1.
    Velichko S; Zhou X; Zhu L; Anderson JD; Wu R; Chen Y
    PLoS One; 2016; 11(10):e0163323. PubMed ID: 27723765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis.
    Hüffmeier U; Uebe S; Ekici AB; Bowes J; Giardina E; Korendowych E; Juneblad K; Apel M; McManus R; Ho P; Bruce IN; Ryan AW; Behrens F; Lascorz J; Böhm B; Traupe H; Lohmann J; Gieger C; Wichmann HE; Herold C; Steffens M; Klareskog L; Wienker TF; Fitzgerald O; Alenius GM; McHugh NJ; Novelli G; Burkhardt H; Barton A; Reis A
    Nat Genet; 2010 Nov; 42(11):996-9. PubMed ID: 20953186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syk mediates IL-17-induced CCL20 expression by targeting Act1-dependent K63-linked ubiquitination of TRAF6.
    Wu NL; Huang DY; Tsou HN; Lin YC; Lin WW
    J Invest Dermatol; 2015 Feb; 135(2):490-498. PubMed ID: 25202827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRAF3IP2 gene and systemic lupus erythematosus: association with disease susceptibility and pericarditis development.
    Perricone C; Ciccacci C; Ceccarelli F; Di Fusco D; Spinelli FR; Cipriano E; Novelli G; Valesini G; Conti F; Borgiani P
    Immunogenetics; 2013 Oct; 65(10):703-9. PubMed ID: 23836313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of Act1, a NF-κB-activating protein, in IL-6 and IL-8 levels induced by IL-17 stimulation in SW982 cells.
    Lv F; Song LJ; Wang XH; Qiu F; Li XF
    Pharm Biol; 2013 Nov; 51(11):1444-50. PubMed ID: 23862741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2.
    Ellinghaus E; Ellinghaus D; Stuart PE; Nair RP; Debrus S; Raelson JV; Belouchi M; Fournier H; Reinhard C; Ding J; Li Y; Tejasvi T; Gudjonsson J; Stoll SW; Voorhees JJ; Lambert S; Weidinger S; Eberlein B; Kunz M; Rahman P; Gladman DD; Gieger C; Wichmann HE; Karlsen TH; Mayr G; Albrecht M; Kabelitz D; Mrowietz U; Abecasis GR; Elder JT; Schreiber S; Weichenthal M; Franke A
    Nat Genet; 2010 Nov; 42(11):991-5. PubMed ID: 20953188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual Role of Act1 in Keratinocyte Differentiation and Host Defense: TRAF3IP2 Silencing Alters Keratinocyte Differentiation and Inhibits IL-17 Responses.
    Lambert S; Swindell WR; Tsoi LC; Stoll SW; Elder JT
    J Invest Dermatol; 2017 Jul; 137(7):1501-1511. PubMed ID: 28274739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease.
    Qian Y; Liu C; Hartupee J; Altuntas CZ; Gulen MF; Jane-Wit D; Xiao J; Lu Y; Giltiay N; Liu J; Kordula T; Zhang QW; Vallance B; Swaidani S; Aronica M; Tuohy VK; Hamilton T; Li X
    Nat Immunol; 2007 Mar; 8(3):247-56. PubMed ID: 17277779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement for both JAK-mediated PI3K signaling and ACT1/TRAF6/TAK1-dependent NF-kappaB activation by IL-17A in enhancing cytokine expression in human airway epithelial cells.
    Huang F; Kao CY; Wachi S; Thai P; Ryu J; Wu R
    J Immunol; 2007 Nov; 179(10):6504-13. PubMed ID: 17982039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CIKS/Act1-mediated signaling by IL-17 cytokines in context: implications for how a CIKS gene variant may predispose to psoriasis.
    Sønder SU; Paun A; Ha HL; Johnson PF; Siebenlist U
    J Immunol; 2012 Jun; 188(12):5906-14. PubMed ID: 22581863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of the unique SEFIR domain from human interleukin 17 receptor A reveals a composite ligand-binding site containing a conserved α-helix for Act1 binding and IL-17 signaling.
    Zhang B; Liu C; Qian W; Han Y; Li X; Deng J
    Acta Crystallogr D Biol Crystallogr; 2014 May; 70(Pt 5):1476-83. PubMed ID: 24816115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor.
    Chang SH; Park H; Dong C
    J Biol Chem; 2006 Nov; 281(47):35603-7. PubMed ID: 17035243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis.
    Boisson B; Wang C; Pedergnana V; Wu L; Cypowyj S; Rybojad M; Belkadi A; Picard C; Abel L; Fieschi C; Puel A; Li X; Casanova JL
    Immunity; 2013 Oct; 39(4):676-86. PubMed ID: 24120361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN regulatory factor-1 is required for the up-regulation of the CD40-NF-kappa B activator 1 axis during airway inflammation.
    Zhao Z; Qian Y; Wald D; Xia YF; Geng JG; Li X
    J Immunol; 2003 Jun; 170(11):5674-80. PubMed ID: 12759449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.